Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead [Yahoo! Finance Canada]
RECKITT BENCKISR GP S/ADR (RBGLY)
NASDAQ:AMEX Investor Relations:
rb.com/investors
Company Research
Source: Yahoo! Finance Canada
(Reuters) - A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness. Litigation over the formulas has raised alarm from doctors who say that it could threaten the formulas' availability or affect medical decisions. CEOs for both Reckitt and Abbott have said the companies may exit the premature formula market. "Companies have to clearly and unambiguously tell us the truth about their products, especially those intended for the smallest and most vulnerable human beings on the planet," Tim Cronin, representing Elizabeth Whitfield and her son Kaine, told the jury in St. Louis, Missouri, in his closing argument at the end of a five-week trial. Cronin said the companies failed to warn that their premature baby formulas could cause necrotizing enterocolitis, and that Kaine got the disease as
Show less
Read more
Impact Snapshot
Event Time:
RBGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RBGLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RBGLY alerts
High impacting RECKITT BENCKISR GP S/ADR news events
Weekly update
A roundup of the hottest topics
RBGLY
News
- Study reveals sick people coughing and sneezing can transfer tens of thousands of organisms to soft surfaces [Yahoo! Finance]Yahoo! Finance
- Should We Be Delighted With Reckitt Benckiser Group plc's (LON:RKT) ROE Of 19%? [Yahoo! Finance]Yahoo! Finance
- Reckitt Benckiser Group plc (OTCMKTS: RBGLY) was downgraded by analysts at Sanford C. Bernstein from a "strong-buy" rating to a "hold" rating.MarketBeat
- Reckitt, Abbott surge after winning an NEC case [Yahoo! Finance]Yahoo! Finance
- Mead Johnson Welcomes Defense Verdict in Whitfield Case [Yahoo! Finance]Yahoo! Finance